Statistical Methods for Estimating the Protective Effects of Immune Markers Using Test-Negative Designs
Middleton, C. E.; Larremore, D. B.
Show abstract
While widely used to study vaccine effectiveness, test negative designs (TND) also provide a platform for identifying and quantifying immunological correlates of protection against disease. A key component of such studies is the protection function, the mathematical relationship between the value of an immunological assay and the relative risk of disease. This function is often estimated using logistic regression, comparing the odds of disease at a given assay value to the odds at assay value zero. Here, we show through mathematical analysis and simulation experiments that logistic regression, while common, fundamentally constrains the functional forms of protection that can be inferred from data in TNDs, potentially leading to overly simplistic estimates of the protection function. To address this limitation, we adapt and analyze a scaled logit model, originally developed for case-control data, as a flexible alternative that allows for greater flexibility in estimating protection functions from TND data. We demonstrate that this approach improves accuracy across a range of biologically plausible protection functions, highlight conditions under which it may fail, and provide practical guidance for researchers to adopt it as a new standard for TND studies evaluating correlates of protection.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Estimating cumulative incidence of SARS-CoV-2 with imperfect serological tests: a cutoff-free approach 96%
- Serosolver: an open source tool to infer epidemiological and immunological dynamics from serological data 95%
- Models of SIV rebound after treatment interruption that involve multiple reactivation events 95%
Similar papers in this journal
- Optimal test allocation strategy during the COVID-19 pandemic and beyond 95%
- Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is Vaccinated 95%
- A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Québec Administrative Data 94%
Similar papers in this journal
- Mechanistic models of humoral kinetics following COVID-19 vaccination 95%
- Interventions targeting nonsymptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case-study 94%
- Adaptive vaccination may be needed to eliminate COVID-19: Results from a runtime-alterable strain-drift and waning-immunity model 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.